Because the incidence of musculoskeletal tumors is rather low compared with that of other cancers, education and training continue to be insufficient to nurture tumor specialists in orthopedics, pathology, and diagnostic radiology. Owing to the wide variety of histological findings and diagnostic image information, it takes more than 10 years to nurture and equip an orthopedic surgeon with the sufficient level of diagnostic skill. Furthermore, the degree of a resection and the reconstruction methods will significantly influence postoperative function, thus only a few orthopedic surgeons can reconstruct satisfactory functions by performing a safe resection. In addition, the operating time is often very long and there is the possibility that the patient's condition will take a sudden turn for worse; therefore, the working environment is very challenging. Under such circumstances, the number of candidates for becoming tumor specialists has been decreasing in the field of orthopedic surgery.

Another issue is that some experienced surgeons with good skills in diagnosis and treatment leave hospitals and start private practices. In Europe and the United States, the inheritance of diagnostic and surgical techniques and the assurance of technical levels are strictly maintained by the residency system. Moreover, the medical service system is established in a way so that even hospital doctors can receive medical service fees commensurate with their efforts. In Japan, however, such a residency system has not been established. Accordingly, diagnostic and surgical skills are acquired through a doctor's personal efforts. In addition, it is difficult to objectively judge whether a certain skill level has been achieved, and personal effort cannot be quantified. Consequently, hospital doctors, realizing that medical service fees are almost always fixed regardless of their efforts, tend to go into private practice in order to obtain a reasonable income that will be commensurate with their work.

Because the nurturing of tumor specialists has been inconsistent, university hospitals and regional cancer specialist hospitals have only barely implemented the development of specialists and transmission of the legacy of diagnostic and surgical techniques. Unfortunately, even this tenuous system has become further unsettled by the recent medical service reform.

The campaign of the Bone and Joint Decade will soon be concluded. In the next decade, there is every possibility that specialists in musculoskeletal tumors will be the first to decrease in number. It will be difficult to pass on the accumulated knowledge and technique of diagnosis and surgical procedures. In addition, it may become a situation where important technologies have already been lost before the loss is noticed.

What should be done to secure the necessary number of specialists in musculoskeletal tumors? First, in addition to the essential technical training such as emergency procedures and general management, it is strongly recommended that postgraduate clinical training include both cross-sectional and fundamental training in the diagnosis and treatment of musculoskeletal tumors. The contents of the latter half of clinical training should be strictly prescribed, and the trainee should be rotated through several educational institutions for 3 to 5 years. The educational institutions need not be limited to university hospitals; it is necessary, however, to choose hospitals where the trainee can be exposed to and experience more than a limited number of clinical cases. To become qualified, the candidate should be required to pass a specialist's examination.

For a specialist already engaged in the diagnosis and treatment of musculoskeletal tumors, an advanced examination should be administered, to include technical evaluation of the performance in surgery. It is desirable that the successful candidate will be highly valued as a musculoskeletal oncologist and thus will be guaranteed a sufficient income. In the meantime, the number of doctors in every medical domain should be specified as part of a national policy aiming for a medical delivery system and service that provide great relief.

Only this kind of medical service system can establish an environment in which the tumor specialist who deals with rare cancers can work without anxiety. Only such nurturing of reliable doctors can assure the transmission of the significant technologies. To prevent the hollowing out of medicine, the reconstruction of the medical service system is the most important and urgent issue that needs to be addressed and understood by the general public.
